{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:28:57Z","timestamp":1793039337632,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007653","name":"Universit\u00e4tsklinikum Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Intestinal epithelial overexpression of the Th17 cell chemoattractant CCL20 is implicated in inflammatory bowel disease and influenced by <jats:italic>NOD2<\/jats:italic> mutations in Crohn\u2019s disease. Vitamin D metabolites have been shown to ameliorate inflammatory bowel disease. Considering <jats:italic>NOD2<\/jats:italic> mutations in Crohn\u2019s disease, we investigated whether Vitamin D deficiency (serum 25-hydroxyvitamin D concentration\u2009&lt;\u200920\u00a0ng\/mL) increases circulating CCL20 levels in inflammatory bowel disease patients and healthy controls and whether active 1,25-dihydroxyvitamin D (calcitriol) downregulates systemic and intestinal CCL20 expression. In a cross-sectional study, serum concentrations of CCL20, 25-hydroxyvitamin D, and calcitriol were measured in 170 <jats:italic>NOD2<\/jats:italic>-genotyped Crohn\u2019s disease patients, 80 ulcerative colitis patients, and 60 healthy controls. Additionally, the effect of calcitriol on experimentally induced CCL20 expression was examined using human intestinal epithelial HT-29 cells. Multivariable linear regression analyses revealed that both the diagnosis of inflammatory bowel disease and vitamin D deficiency were independently associated with elevated CCL20 levels. Compared to healthy controls, Crohn\u2019s disease patients and ulcerative colitis patients exhibited significantly higher circulating CCL20 levels. Unlike in Crohn\u2019s disease patients, vitamin D deficiency was associated with higher CCL20 levels in healthy controls and ulcerative colitis patients, whereas the calcitriol\/25-hydroxyvitamin D activation ratios were negatively correlated with serum CCL20 levels in healthy controls and ulcerative colitis patients with sufficient serum 25-hydroxyvitamin D status. Furthermore, calcitriol markedly inhibited intestinal epithelial induction of CCL20. In Crohn\u2019s disease patients, cholecalciferol supplementation was associated with lower serum CCL20 levels, which were unaffected by <jats:italic>NOD2<\/jats:italic> mutations. These findings suggest that although vitamin D metabolites may downregulate CCL20 expression in healthy controls and ulcerative colitis patients, this regulatory effect appears to be impaired in Crohn\u2019s disease patients.<\/jats:p>","DOI":"10.1038\/s41598-025-05094-x","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T10:31:56Z","timestamp":1750415516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["CCL20 expression is elevated in inflammatory bowel disease and attenuated by vitamin D metabolites"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8698-6103","authenticated-orcid":false,"given":"Johannes","family":"Stallhofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Reichl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lauseker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Waldenmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga Paula","family":"T\u00f6r\u00f6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Mayerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Olszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Frasheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Breiteneicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6101-5244","authenticated-orcid":false,"given":"Andreas","family":"Stallmach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Diegelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Beigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"5094_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor, B., Gardet, A. & Xavier, R. J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307\u2013317. https:\/\/doi.org\/10.1038\/nature10209 (2011).","journal-title":"Nature"},{"key":"5094_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1053\/j.gastro.2019.01.002","volume":"156","author":"S Coward","year":"2019","unstructured":"Coward, S. et al. Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology 156, 1345\u20131353. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.002 (2019).","journal-title":"Gastroenterology"},{"key":"5094_CR3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2019.04.016","volume":"157","author":"D Piovani","year":"2019","unstructured":"Piovani, D. et al. Environmental risk factors for inflammatory bowel diseases: An umbrella review of meta-analyses. Gastroenterology 157, 647\u2013659. https:\/\/doi.org\/10.1053\/j.gastro.2019.04.016 (2019).","journal-title":"Gastroenterology"},{"key":"5094_CR4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1053\/j.gastro.2011.11.040","volume":"142","author":"AN Ananthakrishnan","year":"2012","unstructured":"Ananthakrishnan, A. N. et al. Higher predicted vitamin D status is associated with reduced risk of Crohn\u2019s disease. Gastroenterology 142, 482\u2013489. https:\/\/doi.org\/10.1053\/j.gastro.2011.11.040 (2012).","journal-title":"Gastroenterology"},{"key":"5094_CR5","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1172\/JCI65842","volume":"123","author":"W Liu","year":"2013","unstructured":"Liu, W. et al. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J. Clin. Invest. 123, 3983\u20133996. https:\/\/doi.org\/10.1172\/JCI65842 (2013).","journal-title":"J. Clin. Invest."},{"key":"5094_CR6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature10228","volume":"475","author":"E Esplugues","year":"2011","unstructured":"Esplugues, E. et al. Control of TH17 cells occurs in the small intestine. Nature 475, 514\u2013518. https:\/\/doi.org\/10.1038\/nature10228 (2011).","journal-title":"Nature"},{"key":"5094_CR7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1152\/ajpgi.00409.2006","volume":"292","author":"K Katchar","year":"2007","unstructured":"Katchar, K., Kelly, C. P., Keates, S., O\u2019Brien, M. J. & Keates, A. C. MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 292, 1263\u20131271. https:\/\/doi.org\/10.1152\/ajpgi.00409.2006 (2007).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"5094_CR8","doi-asserted-by":"publisher","first-page":"G710","DOI":"10.1152\/ajpgi.2001.280.4.G710","volume":"280","author":"A Izadpanah","year":"2001","unstructured":"Izadpanah, A., Dwinell, M. B., Eckmann, L., Varki, N. M. & Kagnoff, M. F. Regulated MIP-3alpha\/CCL20 production by human intestinal epithelium: Mechanism for modulating mucosal immunity. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G710-719. https:\/\/doi.org\/10.1152\/ajpgi.2001.280.4.G710 (2001).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"5094_CR9","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1002\/eji.200324347","volume":"33","author":"R Varona","year":"2003","unstructured":"Varona, R., Cadenas, V., Flores, J., Martinez, A. C. & Marquez, G. CCR6 has a non-redundant role in the development of inflammatory bowel disease. Eur. J. Immunol. 33, 2937\u20132946. https:\/\/doi.org\/10.1002\/eji.200324347 (2003).","journal-title":"Eur. J. Immunol."},{"key":"5094_CR10","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/mi.2013.5","volume":"6","author":"Y Sugiura","year":"2013","unstructured":"Sugiura, Y. et al. TLR1-induced chemokine production is critical for mucosal immunity against Yersinia enterocolitica. Mucosal Immunol. 6, 1101\u20131109. https:\/\/doi.org\/10.1038\/mi.2013.5 (2013).","journal-title":"Mucosal Immunol."},{"key":"5094_CR11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/gut.51.6.818","volume":"51","author":"JH Kwon","year":"2002","unstructured":"Kwon, J. H., Keates, S., Bassani, L., Mayer, L. F. & Keates, A. C. Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. Gut 51, 818\u2013826. https:\/\/doi.org\/10.1136\/gut.51.6.818 (2002).","journal-title":"Gut"},{"key":"5094_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/mi.2008.84","volume":"2","author":"C Wang","year":"2009","unstructured":"Wang, C., Kang, S. G., Lee, J., Sun, Z. & Kim, C. H. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol. 2, 173\u2013183. https:\/\/doi.org\/10.1038\/mi.2008.84 (2009).","journal-title":"Mucosal Immunol."},{"key":"5094_CR13","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1084\/jem.20070663","volume":"204","author":"F Annunziato","year":"2007","unstructured":"Annunziato, F. et al. Phenotypic and functional features of human Th17 cells. J Exp Med 204, 1849\u20131861. https:\/\/doi.org\/10.1084\/jem.20070663 (2007).","journal-title":"J Exp Med"},{"key":"5094_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141710","volume":"10","author":"HK Skovdahl","year":"2015","unstructured":"Skovdahl, H. K. et al. Expression of CCL20 and its corresponding receptor CCR6 Is enhanced in active inflammatory bowel disease, and TLR3 mediates CCL20 expression in colonic epithelial cells. PLoS ONE 10, e0141710. https:\/\/doi.org\/10.1371\/journal.pone.0141710 (2015).","journal-title":"PLoS ONE"},{"key":"5094_CR15","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1097\/MIB.0000000000000121","volume":"20","author":"M Friedrich","year":"2014","unstructured":"Friedrich, M., Diegelmann, J., Beigel, F. & Brand, S. IL-17A alone weakly affects the transcriptome of intestinal epithelial cells but strongly modulates the TNF-alpha-induced expression of inflammatory mediators and inflammatory bowel disease susceptibility genes. Inflamm. Bowel Dis. 20, 1502\u20131515. https:\/\/doi.org\/10.1097\/MIB.0000000000000121 (2014).","journal-title":"Inflamm. Bowel Dis."},{"key":"5094_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2012.2","volume":"3","author":"C Cayatte","year":"2012","unstructured":"Cayatte, C. et al. Biomarkers of therapeutic response in the IL-23 pathway in inflammatory bowel disease. Clin. Transl. Gastroenterol. 3, e10. https:\/\/doi.org\/10.1038\/ctg.2012.2 (2012).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"5094_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/ibd.20339","volume":"14","author":"J Seiderer","year":"2008","unstructured":"Seiderer, J. et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohn\u2019s disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm. Bowel Dis. 14, 437\u2013445. https:\/\/doi.org\/10.1002\/ibd.20339 (2008).","journal-title":"Inflamm. Bowel Dis."},{"key":"5094_CR18","doi-asserted-by":"publisher","first-page":"G827","DOI":"10.1152\/ajpgi.00513.2005","volume":"290","author":"S Brand","year":"2006","unstructured":"Brand, S. et al. IL-22 is increased in active Crohn\u2019s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G827-838. https:\/\/doi.org\/10.1152\/ajpgi.00513.2005 (2006).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"5094_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/ibd.20315","volume":"14","author":"S Schmechel","year":"2008","unstructured":"Schmechel, S. et al. Linking genetic susceptibility to Crohn\u2019s disease with Th17 cell function: IL-22 serum levels are increased in Crohn\u2019s disease and correlate with disease activity and IL23R genotype status. Inflamm. Bowel Dis. 14, 204\u2013212. https:\/\/doi.org\/10.1002\/ibd.20315 (2008).","journal-title":"Inflamm. Bowel Dis."},{"key":"5094_CR20","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1136\/gut.2007.130112","volume":"58","author":"J Dambacher","year":"2009","unstructured":"Dambacher, J. et al. The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 58, 1207\u20131217. https:\/\/doi.org\/10.1136\/gut.2007.130112 (2009).","journal-title":"Gut"},{"key":"5094_CR21","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1038\/ajg.2009.163","volume":"104","author":"J Glas","year":"2009","unstructured":"Glas, J. et al. Novel genetic risk markers for ulcerative colitis in the IL2\/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease. Am. J. Gastroenterol. 104, 1737\u20131744. https:\/\/doi.org\/10.1038\/ajg.2009.163 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"5094_CR22","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1097\/MIB.0000000000000515","volume":"21","author":"J Stallhofer","year":"2015","unstructured":"Stallhofer, J. et al. Lipocalin-2 Is a disease activity marker in inflammatory bowel disease regulated by IL-17A, IL-22, and TNF-alpha and modulated by IL23R genotype status. Inflamm. Bowel Dis. 21, 2327\u20132340. https:\/\/doi.org\/10.1097\/MIB.0000000000000515 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"5094_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","volume":"63","author":"C Tillack","year":"2014","unstructured":"Tillack, C. et al. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-gamma-expressing Th1 cells and IL-17A\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment. Gut 63, 567\u2013577. https:\/\/doi.org\/10.1136\/gutjnl-2012-302853 (2014).","journal-title":"Gut"},{"key":"5094_CR24","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1097\/MIB.0000000000000198","volume":"20","author":"M Friedrich","year":"2014","unstructured":"Friedrich, M., Tillack, C., Wollenberg, A., Schauber, J. & Brand, S. IL-36gamma sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn\u2019s disease. Inflamm. Bowel Dis. 20, 1891\u20131901. https:\/\/doi.org\/10.1097\/MIB.0000000000000198 (2014).","journal-title":"Inflamm. Bowel Dis."},{"key":"5094_CR25","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/mi.2014.124","volume":"8","author":"M Friedrich","year":"2015","unstructured":"Friedrich, M., Diegelmann, J., Schauber, J., Auernhammer, C. J. & Brand, S. Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease. Mucosal Immunol. 8, 943\u2013958. https:\/\/doi.org\/10.1038\/mi.2014.124 (2015).","journal-title":"Mucosal Immunol."},{"key":"5094_CR26","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1136\/gut.2008.163667","volume":"58","author":"S Brand","year":"2009","unstructured":"Brand, S. Crohn\u2019s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn\u2019s disease. Gut 58, 1152\u20131167. https:\/\/doi.org\/10.1136\/gut.2008.163667 (2009).","journal-title":"Gut"},{"key":"5094_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119\u2013124. https:\/\/doi.org\/10.1038\/nature11582 (2012).","journal-title":"Nature"},{"key":"5094_CR28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1074\/jbc.M110.163790","volume":"286","author":"MT Palmer","year":"2011","unstructured":"Palmer, M. T. et al. Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J Biol Chem 286, 997\u20131004. https:\/\/doi.org\/10.1074\/jbc.M110.163790 (2011).","journal-title":"J Biol Chem"},{"key":"5094_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/intimm\/dxr045","volume":"23","author":"D Bruce","year":"2011","unstructured":"Bruce, D., Yu, S., Ooi, J. H. & Cantorna, M. T. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int. Immunol. 23, 519\u2013528. https:\/\/doi.org\/10.1093\/intimm\/dxr045 (2011).","journal-title":"Int. Immunol."},{"key":"5094_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012925","volume":"5","author":"JH Chang","year":"2010","unstructured":"Chang, J. H., Cha, H. R., Lee, D. S., Seo, K. Y. & Kweon, M. N. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS ONE 5, e12925. https:\/\/doi.org\/10.1371\/journal.pone.0012925 (2010).","journal-title":"PLoS ONE"},{"key":"5094_CR31","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1210\/en.2014-1647","volume":"156","author":"E Karkeni","year":"2015","unstructured":"Karkeni, E. et al. Vitamin D limits chemokine expression in adipocytes and macrophage migration in vitro and in male mice. Endocrinology 156, 1782\u20131793. https:\/\/doi.org\/10.1210\/en.2014-1647 (2015).","journal-title":"Endocrinology"},{"key":"5094_CR32","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.1167\/iovs.15-17768","volume":"56","author":"RY Reins","year":"2015","unstructured":"Reins, R. Y., Baidouri, H. & McDermott, A. M. Vitamin D activation and function in human corneal epithelial cells during TLR-induced inflammation. Invest. Ophthalmol. Vis. Sci. 56, 7715\u20137727. https:\/\/doi.org\/10.1167\/iovs.15-17768 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"5094_CR33","doi-asserted-by":"publisher","first-page":"10603","DOI":"10.3390\/ijms231810603","volume":"23","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. 1,25-dihydroxyvitamin D(3) negatively regulates the inflammatory response to porcine epidemic diarrhea virus infection by inhibiting NF-kappaB and JAK\/STAT signaling pathway in IPEC-J2 porcine epithelial cells. Int. J. Mol. Sci. 23, 10603. https:\/\/doi.org\/10.3390\/ijms231810603 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"5094_CR34","doi-asserted-by":"publisher","first-page":"163789","DOI":"10.1172\/jci.insight.163789","volume":"8","author":"MK Ernst","year":"2023","unstructured":"Ernst, M. K. et al. Vitamin D3 and deconvoluting a rash. JCI Insight 8, 163789. https:\/\/doi.org\/10.1172\/jci.insight.163789 (2023).","journal-title":"JCI Insight"},{"key":"5094_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/jcp.20739","volume":"209","author":"B Begue","year":"2006","unstructured":"Begue, B. et al. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop. J. Cell Physiol. 209, 241\u2013252. https:\/\/doi.org\/10.1002\/jcp.20739 (2006).","journal-title":"J. Cell Physiol."},{"key":"5094_CR36","doi-asserted-by":"publisher","first-page":"42984","DOI":"10.1074\/jbc.M405410200","volume":"279","author":"JC Bambou","year":"2004","unstructured":"Bambou, J. C. et al. In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. J. Biol. Chem. 279, 42984\u201342992. https:\/\/doi.org\/10.1074\/jbc.M405410200 (2004).","journal-title":"J. Biol. Chem."},{"key":"5094_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12967-019-2070-5","volume":"17","author":"XX Li","year":"2019","unstructured":"Li, X. X. et al. Vitamin D deficiency associated with Crohn\u2019s disease and ulcerative colitis: A meta-analysis of 55 observational studies. J. Transl. Med. 17, 323. https:\/\/doi.org\/10.1186\/s12967-019-2070-5 (2019).","journal-title":"J. Transl. Med."},{"key":"5094_CR38","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1053\/j.gastro.2008.04.020","volume":"135","author":"L Shang","year":"2008","unstructured":"Shang, L. et al. Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology 135, 529\u2013538. https:\/\/doi.org\/10.1053\/j.gastro.2008.04.020 (2008).","journal-title":"Gastroenterology"},{"key":"5094_CR39","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1053\/j.gastro.2020.11.015","volume":"160","author":"R Lu","year":"2021","unstructured":"Lu, R. et al. Paneth cell alertness to pathogens maintained by vitamin D receptors. Gastroenterology 160, 1269\u20131283. https:\/\/doi.org\/10.1053\/j.gastro.2020.11.015 (2021).","journal-title":"Gastroenterology"},{"key":"5094_CR40","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1136\/gut.2003.036657","volume":"53","author":"MT Abreu","year":"2004","unstructured":"Abreu, M. T. et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn\u2019s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 53, 1129\u20131136. https:\/\/doi.org\/10.1136\/gut.2003.036657 (2004).","journal-title":"Gut"},{"key":"5094_CR41","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1097\/MIB.0000000000000158","volume":"20","author":"Y Chen","year":"2014","unstructured":"Chen, Y. et al. MicroRNA-346 mediates tumor necrosis factor alpha-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases. Inflamm. Bowel Dis. 20, 1910\u20131918. https:\/\/doi.org\/10.1097\/MIB.0000000000000158 (2014).","journal-title":"Inflamm. Bowel Dis."},{"key":"5094_CR42","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1136\/gutjnl-2014-307436","volume":"64","author":"S Wu","year":"2015","unstructured":"Wu, S. et al. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut 64, 1082\u20131094. https:\/\/doi.org\/10.1136\/gutjnl-2014-307436 (2015).","journal-title":"Gut"},{"key":"5094_CR43","doi-asserted-by":"publisher","first-page":"11943","DOI":"10.1038\/s41598-020-69128-2","volume":"10","author":"JFP Medeiros","year":"2020","unstructured":"Medeiros, J. F. P. et al. The impact of vitamin D supplementation on VDR gene expression and body composition in monozygotic twins: Randomized controlled trial. Sci. Rep. 10, 11943. https:\/\/doi.org\/10.1038\/s41598-020-69128-2 (2020).","journal-title":"Sci. Rep."},{"key":"5094_CR44","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/ecco-jcc\/jjy025","volume":"12","author":"OH Nielsen","year":"2018","unstructured":"Nielsen, O. H., Rejnmark, L. & Moss, A. C. Role of vitamin D in the natural history of inflammatory bowel disease. J. Crohns Colitis 12, 742\u2013752. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy025 (2018).","journal-title":"J. Crohns Colitis"},{"key":"5094_CR45","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/apt.15506","volume":"50","author":"J Gubatan","year":"2019","unstructured":"Gubatan, J., Chou, N. D., Nielsen, O. H. & Moss, A. C. Systematic review with meta-analysis: Association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease. Aliment Pharmacol. Ther. 50, 1146\u20131158. https:\/\/doi.org\/10.1111\/apt.15506 (2019).","journal-title":"Aliment Pharmacol. Ther."},{"key":"5094_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.mce.2016.11.028","volume":"453","author":"A Barbachano","year":"2017","unstructured":"Barbachano, A. et al. The endocrine vitamin D system in the gut. Mol. Cell Endocrinol. 453, 79\u201387. https:\/\/doi.org\/10.1016\/j.mce.2016.11.028 (2017).","journal-title":"Mol. Cell Endocrinol."},{"key":"5094_CR47","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1038\/s41467-020-19793-8","volume":"11","author":"RL Thomas","year":"2020","unstructured":"Thomas, R. L. et al. Vitamin D metabolites and the gut microbiome in older men. Nat. Commun. 11, 5997. https:\/\/doi.org\/10.1038\/s41467-020-19793-8 (2020).","journal-title":"Nat. Commun."},{"key":"5094_CR48","doi-asserted-by":"publisher","first-page":"00450","DOI":"10.14309\/ctg.0000000000000450","volume":"13","author":"J Stallhofer","year":"2022","unstructured":"Stallhofer, J. et al. Iron deficiency in inflammatory bowel disease is associated with low levels of vitamin D modulating serum hepcidin and intestinal ceruloplasmin expression. Clin. Transl. Gastroenterol. 13, 00450. https:\/\/doi.org\/10.14309\/ctg.0000000000000450 (2022).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"5094_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jneuroim.2009.05.012","volume":"213","author":"W Royal 3rd","year":"2009","unstructured":"Royal, W. 3rd., Mia, Y., Li, H. & Naunton, K. Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. J. Neuroimmunol. 213, 135\u2013141. https:\/\/doi.org\/10.1016\/j.jneuroim.2009.05.012 (2009).","journal-title":"J. Neuroimmunol."},{"key":"5094_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.annepidem.2007.12.001","volume":"19","author":"MF Holick","year":"2009","unstructured":"Holick, M. F. Vitamin D status: Measurement, interpretation, and clinical application. Ann. Epidemiol. 19, 73\u201378. https:\/\/doi.org\/10.1016\/j.annepidem.2007.12.001 (2009).","journal-title":"Ann. Epidemiol."},{"key":"5094_CR51","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00198-009-0954-6","volume":"20","author":"A Mithal","year":"2009","unstructured":"Mithal, A. et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos. Int. 20, 1807\u20131820. https:\/\/doi.org\/10.1007\/s00198-009-0954-6 (2009).","journal-title":"Osteoporos. Int."},{"key":"5094_CR52","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick, M. F. Vitamin D deficiency. N. Engl. J. Med. 357, 266\u2013281. https:\/\/doi.org\/10.1056\/NEJMra070553 (2007).","journal-title":"N. Engl. J. Med."},{"key":"5094_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.envint.2018.11.052","volume":"122","author":"SE Mousavi","year":"2019","unstructured":"Mousavi, S. E., Amini, H., Heydarpour, P., Amini Chermahini, F. & Godderis, L. Air pollution, environmental chemicals, and smoking may trigger vitamin D deficiency: Evidence and potential mechanisms. Environ. Int. 122, 67\u201390. https:\/\/doi.org\/10.1016\/j.envint.2018.11.052 (2019).","journal-title":"Environ. Int."},{"key":"5094_CR54","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best, W. R., Becktel, J. M., Singleton, J. W. & Kern, F. Jr. Development of a Crohn\u2019s disease activity index. National cooperative Crohn\u2019s disease study. Gastroenterology 70, 439\u2013444 (1976).","journal-title":"Gastroenterology"},{"key":"5094_CR55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","volume":"298","author":"D Rachmilewitz","year":"1989","unstructured":"Rachmilewitz, D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial. BMJ 298, 82\u201386. https:\/\/doi.org\/10.1136\/bmj.298.6666.82 (1989).","journal-title":"BMJ"},{"key":"5094_CR56","doi-asserted-by":"publisher","first-page":"12431","DOI":"10.1038\/s41598-021-90558-z","volume":"11","author":"N Ishida","year":"2021","unstructured":"Ishida, N. et al. C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis. Sci. Rep. 11, 12431. https:\/\/doi.org\/10.1038\/s41598-021-90558-z (2021).","journal-title":"Sci. Rep."},{"key":"5094_CR57","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ajg.2015.120","volume":"110","author":"MH Mosli","year":"2015","unstructured":"Mosli, M. H. et al. C-reactive protein, fecal calprotectin, and stool Lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: A systematic review and meta-analysis. Am. J. Gastroenterol. 110, 802\u2013819. https:\/\/doi.org\/10.1038\/ajg.2015.120 (2015).","journal-title":"Am. J. Gastroenterol."},{"key":"5094_CR58","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.molimm.2012.06.007","volume":"52","author":"IH Hiemstra","year":"2012","unstructured":"Hiemstra, I. H., Bouma, G., Geerts, D., Kraal, G. & den Haan, J. M. Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses. Mol. Immunol. 52, 264\u2013272. https:\/\/doi.org\/10.1016\/j.molimm.2012.06.007 (2012).","journal-title":"Mol. Immunol."},{"key":"5094_CR59","unstructured":"Del Valle, H. B., Yaktine, A. L., Taylor, C. L. & Ross, A. C. (2011). Dietary reference intakes for calcium and vitamin D."},{"key":"5094_CR60","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/0148607110381267","volume":"35","author":"A Ulitsky","year":"2011","unstructured":"Ulitsky, A. et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J. Parenter Enteral. Nutr. 35, 308\u2013316. https:\/\/doi.org\/10.1177\/0148607110381267 (2011).","journal-title":"JPEN J. Parenter Enteral. Nutr."},{"key":"5094_CR61","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1080\/10408398.2018.1506734","volume":"59","author":"MDC Ponce de Leon-Rodriguez","year":"2019","unstructured":"Ponce de Leon-Rodriguez, M. D. C., Guyot, J. P. & Laurent-Babot, C. Intestinal in vitro cell culture models and their potential to study the effect of food components on intestinal inflammation. Crit. Rev. Food Sci. Nutr. 59, 3648\u20133666. https:\/\/doi.org\/10.1080\/10408398.2018.1506734 (2019).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"5094_CR62","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1172\/JCI107652","volume":"53","author":"MJ Favus","year":"1974","unstructured":"Favus, M. J., Walling, M. W. & Kimberg, D. V. Effects of dietary calcium restriction and chronic thyroparathyroidectomy on the metabolism of (3H)25-hydroxyvitamin D3 and the active transport of calcium by rat intestine. J. Clin. Invest. 53, 1139\u20131148. https:\/\/doi.org\/10.1172\/JCI107652 (1974).","journal-title":"J. Clin. Invest."},{"key":"5094_CR63","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/ajg.2016.53","volume":"111","author":"TA Kabbani","year":"2016","unstructured":"Kabbani, T. A. et al. Association of vitamin D level with clinical status in inflammatory bowel disease: A 5-year longitudinal study. Am. J. Gastroenterol. 111, 712\u2013719. https:\/\/doi.org\/10.1038\/ajg.2016.53 (2016).","journal-title":"Am. J. Gastroenterol."},{"key":"5094_CR64","doi-asserted-by":"publisher","first-page":"e12662","DOI":"10.1097\/MD.0000000000012662","volume":"97","author":"J Li","year":"2018","unstructured":"Li, J., Chen, N., Wang, D., Zhang, J. & Gong, X. Efficacy of vitamin D in treatment of inflammatory bowel disease: A meta-analysis. Medicine (Baltimore) 97, e12662. https:\/\/doi.org\/10.1097\/MD.0000000000012662 (2018).","journal-title":"Medicine (Baltimore)"},{"key":"5094_CR65","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. J. Clin. Epidemiol. 61, 344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008 (2008).","journal-title":"J. Clin. Epidemiol."},{"key":"5094_CR66","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1055\/s-0034-1385199","volume":"52","author":"JC Preiss","year":"2014","unstructured":"Preiss, J. C. et al. Updated German clinical practice guideline on \u201cDiagnosis and treatment of Crohn\u2019s disease\u201d 2014. Z Gastroenterol 52, 1431\u20131484. https:\/\/doi.org\/10.1055\/s-0034-1385199 (2014).","journal-title":"Z Gastroenterol"},{"key":"5094_CR67","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1055\/s-0031-1281666","volume":"49","author":"A Dignass","year":"2011","unstructured":"Dignass, A. et al. Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011. Z Gastroenterol 49, 1276\u20131341. https:\/\/doi.org\/10.1055\/s-0031-1281666 (2011).","journal-title":"Z Gastroenterol"},{"key":"5094_CR68","doi-asserted-by":"publisher","first-page":"0236421","DOI":"10.1371\/journal.pone.0236421","volume":"15","author":"F Schnitzler","year":"2020","unstructured":"Schnitzler, F. et al. Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn\u2019s disease and active smoking status resulting in Ileal stenosis requiring surgery. PLoS ONE 15, 0236421. https:\/\/doi.org\/10.1371\/journal.pone.0236421 (2020).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05094-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05094-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05094-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:02:49Z","timestamp":1750806169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05094-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5094"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05094-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"16 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study was approved by the Ethics Committee of the Medical Faculty of LMU Munich as the responsible Institutional Review Board (approval code 343\u201309) and adhered to the ethical principles of the 1964 Helsinki Declaration and its later amendments. All subjects provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"20145"}}